Product Images Cetrorelix Acetate
View Photos of Packaging, Labels & Appearance
- cetrorelix-spl-structure - cet05 0000 01
- Fresnius Kabi Logo - cet05 0000 02
- cetrorelix-spl-fig.1 - cet05 0000 03
- cetrorelix-spl-fig.2 - cet05 0000 04
- cetrorelix-spl-fig.3 - cet05 0000 05
- cetrorelix-spl-fig.4 - cet05 0000 06
- cetrorelix-spl-fig.5 - cet05 0000 07
- cetrorelix-spl-fig.6 - cet05 0000 08
- cetrorelix-spl-fig.7 - cet05 0000 09
- cetrorelix-spl-fig.8 - cet05 0000 10
- cetrorelix-spl-fig.9 - cet05 0000 11
- 10 - cet05 0000 12
- cetrorelix-spl-fig.11 - cet05 0000 13
- PACKAGE LABEL - PRINCIPAL DISPLAY – Cetrorelix Acetate Single-Dose Vial Label - cet05 0000 14
- PDP INFO – Cetrorelix Acetate for Injection 286701 PFS - cet05 0000 15
- PACKAGE LABEL - PRINCIPAL DISPLAY – Cetrorelix Acetate Blister Foil Label - cet05 0000 16
- PACKAGE LABEL - PRINCIPAL DISPLAY - Cetrorelix Acetate Kit Carton Labe - cet05 0000 17
Product Label Images
The following 17 images provide visual information about the product associated with Cetrorelix Acetate NDC 65219-292 by Fresenius Kabi Usa, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
cetrorelix-spl-structure - cet05 0000 01
Fresnius Kabi Logo - cet05 0000 02
cetrorelix-spl-fig.1 - cet05 0000 03
cetrorelix-spl-fig.2 - cet05 0000 04
cetrorelix-spl-fig.3 - cet05 0000 05
cetrorelix-spl-fig.4 - cet05 0000 06
cetrorelix-spl-fig.5 - cet05 0000 07
cetrorelix-spl-fig.6 - cet05 0000 08
cetrorelix-spl-fig.7 - cet05 0000 09
cetrorelix-spl-fig.8 - cet05 0000 10
cetrorelix-spl-fig.9 - cet05 0000 11
10 - cet05 0000 12
cetrorelix-spl-fig.11 - cet05 0000 13
PACKAGE LABEL - PRINCIPAL DISPLAY – Cetrorelix Acetate Single-Dose Vial Label - cet05 0000 14
This is product information for a subcutaneous injection indicated for medical use. It is a sterile solution contained in a single-dose vial. The vial should be protected from light and stored refrigerated between 2-8°C. The product contains Cetrorelix Acetate for Injection at a strength of 0.25 mg per vial. The manufacturer is Fresenius Kabi based in Lake Zurich, IL.*
PDP INFO – Cetrorelix Acetate for Injection 286701 PFS - cet05 0000 15
This is a description of a 1 mL prefilled sterile water for injection, USP, with NDC 65219-286-01. The product is manufactured for Fresenius Kahi in Lake Zurich, IL 60047, and it is made in India. The code number is AP/DRUGS/103/97.*
PACKAGE LABEL - PRINCIPAL DISPLAY – Cetrorelix Acetate Blister Foil Label - cet05 0000 16
This text provides information about Cetrorelix Acetate for injection, with details on its packaging (single-dose vial, pre-filled syringe, needles), storage instructions (refrigerated), and proper usage (subcutaneous use only). The manufacturer is Fresenius Kabi. The product has a strength of 5 mg/vial and 0.25 mg/vial. Additional details include lot numbers and expiration dates for tracking purposes.*
PACKAGE LABEL - PRINCIPAL DISPLAY - Cetrorelix Acetate Kit Carton Labe - cet05 0000 17
This is a description of Cetrorelix Acetate for Injection, a medication in vial form containing 0.25 mg of cetrorelix acetate. Each vial also includes 54.8 mg of mannitol. The package includes one pre-filled syringe with diluent for reconstitution. It is intended for subcutaneous use only and must be stored refrigerated at 2-8°C. The medication should be used immediately after reconstitution and kept out of reach of children. Information on dosage and potential side effects is available in the package insert. Report any side effects to FDA at 1-800-FDA-1088.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
